Q1 EPS Estimates for UroGen Pharma Lowered by HC Wainwright
UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) – Equities research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for UroGen Pharma in a report issued on Tuesday, March 11th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of ($0.93) per share for the quarter, down from […]
UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) – Equities research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for UroGen Pharma in a report issued on Tuesday, March 11th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of ($0.93) per share for the quarter, down from […]
